(AGENPARL) – SILVER SPRING lun 01 maggio 2023 FDA conditionally approved Varenzin-CA1 (molidustat oral suspension) the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.
Fonte/Source: http://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-drug-anemia-cats-chronic-kidney-disease